Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)

China flag China · Delayed Price · Currency is CNY
3.090
-0.020 (-0.64%)
Jun 11, 2026, 1:55 PM CST
Market Cap7.83B -16.8%
Revenue (ttm)15.96B -1.5%
Net Income309.80M -53.4%
EPS0.12 -54.1%
Shares Out 2.52B
PE Ratio25.99
Forward PE17.28
Dividendn/a
Ex-Dividend Daten/a
Volume24,016,450
Open3.090
Previous Close3.110
Day's Range3.050 - 3.150
52-Week Range3.050 - 4.880
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHA:600664

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium ... [Read more]

Sector Healthcare
Founded 1991
Employees 10,039
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600664
Full Company Profile

Financial Performance

In 2025, SHA:600664's revenue was 15.96 billion, a decrease of -1.31% compared to the previous year's 16.18 billion. Earnings were 361.60 million, a decrease of -42.50%.

Financial Statements